SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-192108
Filing Date
2021-06-16
Accepted
2021-06-16 16:05:57
Documents
12
Period of Report
2021-06-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d148004d8k.htm   iXBRL 8-K 26266
  Complete submission text file 0001193125-21-192108.txt   149851

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA arwr-20210615.xsd EX-101.SCH 3094
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE arwr-20210615_lab.xml EX-101.LAB 18139
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arwr-20210615_pre.xml EX-101.PRE 11424
5 EXTRACTED XBRL INSTANCE DOCUMENT d148004d8k_htm.xml XML 3367
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38042 | Film No.: 211021546
SIC: 2834 Pharmaceutical Preparations